Laban, Simon <br/><br/>
Sorafenib sensitizes head and neck squamous cell carcinoma cells to ionizing radiation.  [electronic resource] 

 -  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology  Nov 2013 
 - 286-92 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-0887 
<br/><br/><label>Standard No.: </label>10.1016/j.radonc.2013.07.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Carcinoma, Squamous Cell--pathology<br/>Cell Line, Tumor<br/>DNA Repair<br/>Head and Neck Neoplasms--pathology<br/>Humans<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds--therapeutic use<br/>Radiation-Sensitizing Agents--therapeutic use<br/>Sorafenib<br/>Squamous Cell Carcinoma of Head and Neck<br/>raf Kinases--antagonists & inhibitors